Related Experiment Video

Updated: May 19, 2026

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

Vismodegib: a promising drug in the treatment of basal cell carcinomas

Luc Dirix1, Annemie Rutten

  • 1Sint-Augustinus Hospital, Oosterveldlaan 24, Antwerp, Belgium. luc.dirix@gza.be

Future Oncology (London, England)
|August 17, 2012
PubMed

Insights

Vismodegib is a novel hedgehog pathway inhibitor demonstrating efficacy in treating advanced basal cell carcinoma. Clinical trials confirm its favorable safety and risk profile for cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Hedgehog pathway signaling is crucial for embryonic development.
  • Aberrant reactivation of this pathway is implicated in various adult cancers.
  • Vismodegib targets the SMO protein to inhibit hedgehog pathway activity.

Purpose of the Study:

  • To evaluate the clinical pharmacology and efficacy of vismodegib.
  • To assess the safety and tolerability profile of vismodegib.
  • To confirm the benefit:risk profile of vismodegib in advanced basal cell carcinoma.

Main Methods:

  • Preclinical studies indicated potential anti-tumor activity.
  • Clinical pharmacology and Phase I studies assessed drug properties and initial efficacy.
  • A pivotal Phase II clinical trial evaluated vismodegib in advanced basal cell carcinoma patients.

Main Results:

  • Vismodegib exhibits a unique pharmacokinetic profile.
  • The drug demonstrated efficacy in specific tumor types.
  • Vismodegib generally presented a tolerable adverse-event profile.
  • Phase II trial confirmed a favorable benefit:risk ratio for advanced basal cell carcinoma.

Conclusions:

  • Vismodegib is an effective hedgehog pathway inhibitor for advanced basal cell carcinoma.
  • The drug offers a favorable benefit:risk profile, supporting its clinical use.
  • Vismodegib represents a significant advancement in targeted cancer therapy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...